INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 30 September 2013
Total net assets |
£180.0m |
NAV per share |
326.5p |
Share price |
286.5p |
Total value of unquoted investments |
£23.7m |
Total number of portfolio companies |
77 |
Top Five Holdings
Company Name |
% NAV |
Celgene |
8.5 |
Gilead |
7.0 |
Regeneron |
6.8 |
Amgen |
6.5 |
Biogen |
5.8 |
|
----------- |
Total |
34.6 |
Trust Characteristics |
% NAV |
Profitable |
56 |
Becoming Profitable |
13 |
Unprofitable |
31 |
|
----------- |
Total |
100 |
Geographical Allocation |
% NAV |
United States & Canada |
93 |
Europe |
7 |
|
----------- |
Total |
100 |
Quoted/Unquoted allocation |
% NAV |
Quoted |
87 |
Unquoted |
13 |
|
----------- |
Total |
100 |
Subsector |
% NAV |
Therapeutics |
82 |
Life Sciences Tools, Diagnostics & Services |
9 |
Medical Devices |
5 |
Specialty Pharma |
4 |
|
----------- |
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
30 OCTOBER 2013